P. Grundy

发表

Predicting Relapse in Favorable Histology Wilms Tumor Using Gene Expression Analysis: A Report from the Renal Tumor Committee of the Children's Oncology Group

Norman Breslow, Chiang-Ching Huang, Irene B Helenowski, 2009, Clinical Cancer Research.

Amplification and Overexpression of CACNA1E Correlates with Relapse in Favorable Histology Wilms' Tumors

Kathy Pritchard-Jones, Chris Jones, Boo Messahel, 2006, Clinical Cancer Research.

Canadian cancer statistics at a glance: cancer in children

P. Grundy, L. Ellison, P. De, 2009, Canadian Medical Association Journal.

Wilms tumour: prognostic factors, staging, therapy and late effects

P. Babyn, J. Dome, P. Grundy, 2007, Pediatric Radiology.

A third Wilms' tumor locus on chromosome 16q.

A. Feinberg, M. Eccles, A. Reeve, 1992, Cancer research.

Loss of Heterozygosity for Chromosomes 16q and Ip in Wilms' Tumors Predicts an Adverse Outcome'

N. Breslow, M. Paterson, P. Grundy, 2022 .

A pathologic link between Wilms tumor suppressor gene, WT1, and IFI16.

B. Tycko, J. Licht, D. Choubey, 2008, Neoplasia.

Protocol for the examination of specimens from patients with Wilms tumor (nephroblastoma) or other renal tumors of childhood.

J. Srigley, J. Bowen, M. Amin, 2003, Archives of pathology & laboratory medicine.

ETV6-NTRK3 gene fusions and trisomy 11 establish a histogenetic link between mesoblastic nephroma and congenital fibrosarcoma.

P. Sorensen, M. Garnett, T. Pysher, 1998, Cancer research.

Primary nephrectomy and intraoperative tumor spill: report from the Children's Oncology Group (COG) renal tumors committee.

A. Naranjo, Mike K. Chen, J. Dome, 2013, Journal of pediatric surgery.

Evaluation of diagnostic performance of CT for detection of tumor thrombus in children with Wilms tumor: A report from the Children's Oncology Group

James R. Anderson, K. Karolczuk, J. Dome, 2012, Pediatric blood & cancer.

Multicenter study identified molecular blood‐born protein signatures for Wilms Tumor

M. Gessler, Hans-Peter Lenhof, A. Keller, 2012, International journal of cancer.

Quality assessment for Wilms' tumor: a report from the National Wilms' Tumor Study-5.

N. Breslow, D. Green, P. Grundy, 2005, Journal of pediatric surgery.

Cytotoxicity of 2‐chlorodeoxyadenosine and arabinosylcytosine in leukaemic lymphoblasts from paediatric patients: significance of cellular nucleoside transporter content

P. Grundy, A. Paterson, J. Akabutu, 2002, British journal of haematology.

Current issues in Wilms tumor management.

P. Grundy, J. G. Glade Bender, F. Hoffer, 2005, Current problems in cancer.

Modulation of platelet-derived growth factor receptor function in BP3T3, a chemically transformed BALB/c-3T3 cell line.

P. Grundy, C. Scher, S. Bishayee, 1989, Cancer research.

Clinical significance of pulmonary nodules detected by CT and Not CXR in patients treated for favorable histology Wilms tumor on national Wilms tumor studies‐4 and ‐5: A report from the Children's Oncology Group

N. Breslow, James R. Anderson, D. Green, 2012, Pediatric blood & cancer.

Treatment of Wilms tumor relapsing after initial treatment with vincristine and actinomycin D: A report from the National Wilms Tumor Study Group

N. Breslow, R. Macklis, D. Green, 2007, Pediatric blood & cancer.

Management of Wilms' tumour: current practice and future goals.

M. Coppes, J. Dome, P. Grundy, 2004, The Lancet. Oncology.

Clinical Outcome and Biological Predictors of Relapse After Nephrectomy Only for Very Low-risk Wilms Tumor: A Report From Children's Oncology Group AREN0532

James R. Anderson, J. Dome, P. Grundy, 2017, Annals of surgery.

Effects of Acute Exercise on Neutrophils in Pediatric Acute Lymphoblastic Leukemia Survivors: A Pilot Study

K. Courneya, G. Bell, P. Grundy, 2006, Journal of pediatric hematology/oncology.

WT1 mutation and 11P15 loss of heterozygosity predict relapse in very low-risk wilms tumors treated with surgery alone: a children's oncology group study.

James R. Anderson, D. Green, J. Dome, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Outcomes based on histopathologic response to preoperative chemotherapy in children with bilateral Wilms tumor: A prospective study (COG AREN0534)

M. Chintagumpala, J. Dome, P. Grundy, 2022, Cancer.

Augmentation of Therapy for Combined Loss of Heterozygosity 1p and 16q in Favorable Histology Wilms Tumor: A Children's Oncology Group AREN0532 and AREN0533 Study Report.

James R. Anderson, J. Gastier-Foster, J. Dome, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Outcomes of children with favorable histology wilms tumor and peritoneal implants treated in National Wilms Tumor Studies-4 and -5.

James R. Anderson, D. Green, J. Dome, 2010, International journal of radiation oncology, biology, physics.

Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group

N. Breslow, R. Macklis, D. Green, 2008, Pediatric blood & cancer.

Treatment of children with stages II to IV anaplastic Wilms' tumor: a report from the National Wilms' Tumor Study Group.

N. Breslow, D. Green, P. Faria, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The role of surgical excision in the management of relapsed Wilms' tumor patients with pulmonary metastases: a report from the National Wilms' Tumor Study.

N. Breslow, D. Green, P. Grundy, 1991, Journal of pediatric surgery.

Prognostic factors for children with recurrent Wilms' tumor: results from the Second and Third National Wilms' Tumor Study.

N. Breslow, D. Green, A. Evans, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Germline WT1 mutations in Wilms' tumor patients: preliminary results.

N. Breslow, J. Pelletier, D. Green, 1996, Medical and pediatric oncology.

The survivin:fas ratio in pediatric renal tumors.

P. Grundy, A. Sandler, W. Bishop, 2001, Journal of pediatric surgery.

Biological Prognostic Factors in Wilms Tumors

K. Pritchard-Jones, P. Grundy, M. Maschietto, 2014 .

Analysis by array CGH of genomic changes associated with the progression or relapse of Wilms' tumour

A. Ashworth, J. Reis-Filho, R. Natrajan, 2007, The Journal of pathology.

Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group Study AREN0532.

James R. Anderson, J. Dome, P. Grundy, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Genomic imbalances pinpoint potential oncogenes and tumor suppressors in Wilms tumors

P. Grundy, M. Maschietto, D. Carraro, 2016, Molecular Cytogenetics.

Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor : A Report From the Children ' s Oncology Group Study AREN 0532

James R. Anderson, P. Grundy, E. Perlman, 2022 .

WNT5A is regulated by PAX2 and may be involved in blastemal predominant Wilms tumorigenesis.

P. Grundy, Y. Tamimi, Usukuma Ekuere, 2008, Neoplasia.

Paired box genes, PAX-2 and PAX-8, are not frequently mutated in Wilms tumor.

P. Grundy, K. Stone, Y. Tamimi, 2006, Mutation research.

B7-h1 as a biomarker for therapy failure in patients with favorable histology Wilms tumor.

James R. Anderson, A. Retik, P. Grundy, 2013, The Journal of urology.

Constitutional WT1 mutations in Wilms' tumor patients.

N. Breslow, D. Neuberg, J. Pelletier, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Evaluating the ability to detect change of health‐related quality of life in children with Hodgkin disease

P. Grundy, M. Krahn, R. Klaassen, 2010, Cancer.

Nurses provide valuable proxy assessment of the health‐related quality of life of children with Hodgkin disease

P. Grundy, R. Barr, R. Klaassen, 2010, Cancer.

Use of Gemcitabine With Multi-stage Surgical Resection as Successful Second-line Treatment of Metastatic Pancreatoblastoma

P. Grundy, D. Bigam, R. Bhargava, 2013, Journal of pediatric hematology/oncology.

A genome-wide association study identifies susceptibility loci for Wilms tumor

S. Seal, N. Rahman, A. Naranjo, 2012, Nature Genetics.

Fine structure analysis of the WT1 gene in sporadic Wilms tumors.

N. Nowak, J. Pelletier, N. Bardeesy, 1994, Proceedings of the National Academy of Sciences of the United States of America.

The value of surgery in directing therapy for patients with Wilms' tumor with pulmonary disease. A report from the National Wilms' Tumor Study Group (National Wilms' Tumor Study 5).

P. Grundy, P. Ehrlich, M. Ritchey, 2006, Journal of pediatric surgery.

Outcomes of patients with revised stage I clear cell sarcoma of kidney treated in National Wilms Tumor Studies 1-5.

J. Dome, P. Grundy, E. Perlman, 2013, International journal of radiation oncology, biology, physics.

Increased microvascular density predicts relapse in Wilms' tumor.

A. Rademaker, I. Helenowski, P. Grundy, 2003, Journal of pediatric surgery.

Clinicopathologic correlates of loss of heterozygosity in Wilm's tumor: a preliminary analysis.

N. Breslow, P. Grundy, P. Telzerow, 1996, Medical and pediatric oncology.

Treatment of Stage IV Favorable Histology Wilms Tumor With Lung Metastases: A Report From the Children's Oncology Group AREN0533 Study.

James R. Anderson, J. Gastier-Foster, J. Dome, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic Value of Quantifying Apoptosis Factor Expression in Favorable Histology Wilms Tumors

N. Breslow, P. Grundy, M. O'dorisio, 2005, Journal of pediatric hematology/oncology.

Early discontinuation of intravenous antimicrobial therapy in pediatric oncology patients with febrile neutropenia

P. Grundy, Joan L. Robinson, Heather Hodgson-Viden, 2005, BMC pediatrics.

Clinicopathologic findings predictive of relapse in children with stage III favorable-histology Wilms tumor.

N. Breslow, James R. Anderson, D. Green, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of the First Generation of Children's Oncology Group Clinical Trials on Clinical Practice for Wilms Tumor.

M. Chintagumpala, J. Dome, P. Grundy, 2021, Journal of the National Comprehensive Cancer Network : JNCCN.

Advances in Brief ETV 6-NTRK 3 Gene Fusions and Trisomy 11 Establish a Histogenetic Link between Mesoblastic Nephroma and Congenital Fibrosarcoma 1

Stevan, P. Sorensen, P. Grundy, 2006 .

Infantile myofibromatosis: report on a family with autosomal dominant inheritance and variable penetrance.

P. Grundy, C. Sergi, K. Kulkarni, 2012, Journal of pediatric surgery.

Principles and Practice of Pediatric Oncology (Fourth edition)

J. Dome, P. Grundy, E. Perlman, 2004 .

Relaxation of imprinted genes in human cancer

A. Feinberg, P. Grundy, C. Dobry, 1993, Nature.

Recurrent somatic mutation in DROSHA induces microRNA profile changes in Wilms tumour

P. Grundy, D. Carraro, I. Cunha, 2014, Nature Communications.

Delineation of a 1Mb breakpoint region at 1p13 in Wilms tumors by fine‐tiling oligonucleotide array CGH

A. Ashworth, A. Grigoriadis, R. Williams, 2007, Genes, chromosomes & cancer.

The genetics of BWS associated tumors

A. Feinberg, P. Grundy, M. Steenman, 1999 .

Erratum: Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumour

A. Feinberg, P. Grundy, M. Steenman, 1994, Nature Genetics.

Two pairs of male monozygotic twins discordant for Wiedemann-Beckwith syndrome.

F. Bamforth, F. Bernier, P. Grundy, 1996, American journal of medical genetics.

Tumor-associated zinc finger mutations in the CTCF transcription factor selectively alter tts DNA-binding specificity.

A. Feinberg, P. Neiman, Victor V Lobanenkov, 2002, Cancer research.

Identification of a minimal region of loss on the short arm of chromosome 1 in Wilms tumor

P. Grundy, Y. Tamimi, K. Dietrich, 2007, Genes, chromosomes & cancer.

A genome-wide association study identifies susceptibility loci for Wilms tumor

S. Seal, N. Rahman, A. Naranjo, 2012, Nature Genetics.

Familial predisposition to Wilms' tumour does not map to the short arm of chromosome 11

W. Cavenee, Frederick P. Li, P. Grundy, 1988, Nature.

Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study.

N. Breslow, R. Macklis, D. Green, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effect of duration of treatment on treatment outcome and cost of treatment for Wilms' tumor: a report from the National Wilms' Tumor Study Group.

N. Breslow, D. Green, P. Grundy, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comparison between single-dose and divided-dose administration of dactinomycin and doxorubicin for patients with Wilms' tumor: a report from the National Wilms' Tumor Study Group.

N E Breslow, D M Green, N. Breslow, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Identification of novel regions of deletion in familial Wilms' tumor by comparative genomic hybridization.

A. Look, R. Altura, M. Valentine, 1996, Cancer research.

Differential expression of a novel ankyrin containing E3 ubiquitin-protein ligase, Hace1, in sporadic Wilms' tumor versus normal kidney.

Nataliya Melnyk, Marco A Marra, P. Sorensen, 2004, Human molecular genetics.

Complex patterns of chromosome 9 alterations including the p16INK4a locus in Wilms tumours

J. Reis-Filho, R. Natrajan, K. Pritchard-Jones, 2007, Journal of Clinical Pathology.

TP53 Mutational Status Is a Potential Marker for Risk Stratification in Wilms Tumour with Diffuse Anaplasia

James R. Anderson, N. Sebire, T. Chagtai, 2014, PloS one.

Imprinting of the gene encoding a human cyclin-dependent kinase inhibitor, p57KIP2, on chromosome 11p15.

A. Feinberg, S. Elledge, J. Harper, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Molecular profiling reveals frequent gain of MYCN and anaplasia‐specific loss of 4q and 14q in wilms tumor

A. Ashworth, James R. Anderson, T. Chagtai, 2011, Genes, chromosomes & cancer.

Aberrant imprinting of the insulin-like growth factor II receptor gene in Wilms' tumor

C. Polychronakos, P. Grundy, Y. Xu, 1997, Oncogene.

Familial Wiedemann-Beckwith syndrome and a second Wilms tumor locus both map to 11p15.5.

W. Cavenee, Kenneth, P. Grundy, 1989, American journal of human genetics.

Children with idiopathic hemihypertrophy and beckwith-wiedemann syndrome have different constitutional epigenotypes associated with wilms tumor.

A. Feinberg, M. DeBaun, E. Niemitz, 2005, American journal of human genetics.

Outcome of patients with stage II/favorable histology wilms tumor with and without local tumor spill: A report from the National Wilms Tumor Study Group

N. Breslow, D. Green, A. Evans, 2014, Pediatric blood & cancer.

High telomerase reverse transcriptase (hTERT) messenger RNA level correlates with tumor recurrence in patients with favorable histology Wilms' tumor.

N. Breslow, S. Sukumar, L. Carey, 1999, Cancer research.

Long-term Outcomes for Infants With Very Low Risk Wilms Tumor Treated With Surgery Alone in National Wilms Tumor Study-5

N. Breslow, James R. Anderson, R. Macklis, 2010, Annals of surgery.

Hemizygous deletions of chromosome band 16q24 in Wilms tumor: detection by fluorescence in situ hybridization.

A. Look, D. Green, M. Valentine, 1999, Cancer genetics and cytogenetics.

Association of Chromosome 1q Gain With Inferior Survival in Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group.

James R. Anderson, J. Dome, P. Grundy, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Third Wilms' Tumor Locus on Chromosome loq1

Andrew P. Feinberg, Andrew Thompson, David F. Callen, 1992 .

Molecular basis of Wilms' tumor.

P. Grundy, 1997, Cancer treatment and research.

An overview of the clinical and molecular genetics of Wilms' tumor.

M. Coppes, P. Grundy, 1996, Medical and pediatric oncology.

Molecular genetics of Wilms tumor.

D. Haber, M. Coppes, P. Grundy, 1995, Hematology/oncology clinics of North America.

Genetic events in the development of Wilms' tumor.

D. Haber, M. Coppes, P. Grundy, 1994, The New England journal of medicine.

Uniparental disomy occurs infrequently in Wilms tumor patients.

M. Paterson, P. Grundy, W. Zhou, 1994, American journal of human genetics.

Results of the First Prospective Multi-institutional Treatment Study in Children With Bilateral Wilms Tumor (AREN0534): A Report From the Children's Oncology Group

M. Chintagumpala, P. Grundy, E. Perlman, 2017, Annals of surgery.

Barriers to the Enrollment of Children in the Children's Oncology Group Study of Very Low Risk Wilms Tumor: A Report from the Children's Oncology Group

J. Dome, P. Grundy, P. Ehrlich, 2011, Journal of pediatric hematology/oncology.

Reply to B. Royer-Pokora et al

D. Green, J. Dome, P. Grundy, 2011 .

Treatment with nephrectomy only for small, stage I/favorable histology Wilms' tumor: a report from the National Wilms' Tumor Study Group.

N. Breslow, R. Macklis, D. Green, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Detection of preoperative wilms tumor rupture with CT: a report from the Children's Oncology Group.

A. Naranjo, J. Dome, P. Grundy, 2013, Radiology.

Bilateral Wilms' tumor with anaplasia: lessons from the National Wilms' Tumor Study.

P. Argani, D. Green, P. Grundy, 2006, Journal of pediatric surgery.

Influence of radiation therapy delay on abdominal tumor recurrence in patients with favorable histology Wilms' tumor treated on NWTS-3 and NWTS-4: a report from the National Wilms' Tumor Study Group.

N. Breslow, R. Macklis, D. Green, 2003, International journal of radiation oncology, biology, physics.

Results of Treatment for Patients With Multicentric or Bilaterally Predisposed Unilateral Wilms Tumor (AREN0534): A report from the Children's Oncology Group

M. Chintagumpala, J. Dome, P. Grundy, 2020, Cancer.

Treatment of stage I anaplastic Wilms' tumour: a report from the Children's Oncology Group AREN0321 study.

J. Dome, P. Grundy, E. Perlman, 2019, European journal of cancer.

Anaplastic Wilms' tumour, a subtype displaying poor prognosis, harbours p53 gene mutations

N. Nowak, J. Pelletier, N. Bardeesy, 1994, Nature Genetics.

Increased birth weights of National Wilms' Tumor Study patients suggest a growth factor excess.

N. Breslow, W. Leisenring, M. Coppes, 1994, Cancer research.

Treatment outcomes in adults with favorable histologic type Wilms tumor-an update from the National Wilms Tumor Study Group.

N. Breslow, B. Nan, D. Green, 2004, International journal of radiation oncology, biology, physics.

Effect of duration of treatment on treatment outcome for patients with clear-cell sarcoma of the kidney: a report from the National Wilms' Tumor Study Group.

N. Breslow, D. Green, P. Grundy, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Subsets of Very Low Risk Wilms Tumor Show Distinctive Gene Expression, Histologic, and Clinical Features

Norman Breslow, Chiang-Ching Huang, N. Breslow, 2009, Clinical Cancer Research.

Wilms tumor

N. Breslow, D. Green, P. Grundy, 1996, CA: a cancer journal for clinicians.

Gene expression analysis of blastemal component reveals genes associated with relapse mechanism in Wilms tumour.

P. Grundy, H. Brentani, M. Maschietto, 2011, European journal of cancer.

Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group.

N. Breslow, R. Macklis, D. Green, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Fine Mapping of Wilms’ Tumors With 16q Loss of Heterozygosity Localizes the Putative Tumor Suppressor Gene to a Region of 6.7 Megabases

R. Bentley, P. Grundy, M. Skinner, 2003, Annals of Surgical Oncology.

Gain of 1q is associated with adverse outcome in favorable histology Wilms' tumors.

M. Gessler, K. Pritchard-Jones, P. Grundy, 2001, The American journal of pathology.

Specificity Transcription Factor Selectively Alter Its DNA-binding Tumor-associated Zinc Finger Mutations in the CTCF Updated Version

A. Feinberg, P. Neiman, Victor V Lobanenkov, 2001 .

Molecular Profiling of Isolated Histological Components of Wilms Tumor Implicates a Common Role for the Wnt Signaling Pathway in Kidney and Tumor Development

Diogo F. C. Patrão, R. Brentani, S. Sredni, 2008, Oncology.

Clinically relevant subsets identified by gene expression patterns support a revised ontogenic model of Wilms tumor: a Children's Oncology Group Study.

Chiang-Ching Huang, D. Green, S. Gadd, 2012, Neoplasia.

MUTATION OF THE WTl GENE IN WILMS ' TUMORS

Arden, S. Orkin, M. Gessler, 2009 .

The Simpson–Golabi–Behmel gene, GPC3, is not involved in sporadic Wilms tumorigenesis

R. Godbout, P. Grundy, T. Gillan, 2003, American journal of medical genetics. Part A.

Infrequent mutation of the WT1 gene in 77 Wilms' tumors

S. Orkin, S. Sallan, M. Gessler, 1994, Human mutation.

Genetic and Genetic Expression Analyses of Clear Cell Sarcoma of the Kidney

P. Grundy, M. Fritsch, E. Perlman, 2003, Laboratory Investigation.

Gain of 1q is associated with inferior event‐free and overall survival in patients with favorable histology Wilms tumor: A report from the Children's Oncology Group

James R. Anderson, J. Dome, P. Grundy, 2013, Cancer.

Blastemal expression of type I insulin-like growth factor receptor in Wilms' tumors is driven by increased copy number and correlates with relapse.

J. Reis-Filho, Chris Jones, R. Natrajan, 2006, Cancer research.

Stratification of Wilms tumor by genetic and epigenetic analysis

Nazneen Rahman, Neil J. Sebire, Kathy Pritchard-Jones, 2012, Oncotarget.

Management of adults with Wilms’ tumor: recommendations based on international consensus

G. Gatta, M. Coppes, K. Pritchard-Jones, 2011, Expert review of anticancer therapy.

Impact of cyclophosphamide and etoposide on outcome of clear cell sarcoma of the kidney treated on the National Wilms Tumor Study‐5 (NWTS‐5)

James R. Anderson, D. Green, P. Grundy, 2018, Pediatric blood & cancer.

Imaging Characteristics of Nephrogenic Rests Versus Small Wilms Tumors: A Report From the Children's Oncology Group Study AREN03B2.

J. Sandberg, S. Servaes, J. Dome, 2020, AJR. American journal of roentgenology.

Activity of Vincristine and Irinotecan in Diffuse Anaplastic Wilms Tumor and Therapy Outcomes of Stage II to IV Disease: Results of the Children's Oncology Group AREN0321 Study.

James R. Anderson, J. Dome, P. Grundy, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of Surveillance Imaging Modality on Survival After Recurrence in Patients With Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group.

James R. Anderson, D. Green, J. Dome, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Intraoperative spillage of favorable histology wilms tumor cells: influence of irradiation and chemotherapy regimens on abdominal recurrence. A report from the National Wilms Tumor Study Group.

N. Breslow, D. Green, P. Grundy, 2010, International journal of radiation oncology, biology, physics.

Loss of Heterozygosity at 2q37 in Sporadic Wilms' Tumor: Putative Role for miR-562

M. Gessler, Chris Jones, R. Natrajan, 2009, Clinical Cancer Research.

CTNNB1 mutations and overexpression of Wnt/beta-catenin target genes in WT1-mutant Wilms' tumors.

Adam A. Margolin, Adam A Margolin, Benjamin Tycko, 2004, The American journal of pathology.

Frequent hypomethylation in Wilms tumors of pericentromeric DNA in chromosomes 1 and 16.

M. Ehrlich, A. Narayan, P. Grundy, 1999, Cancer genetics and cytogenetics.

Familial Wilms' tumor: a descriptive study.

N. Breslow, J. Olson, P. Grundy, 1996, Medical and pediatric oncology.

Temporal blastemal cell gene expression analysis in the kidney reveals new Wnt and related signaling pathway genes to be essential for Wilms' tumor onset

E. J. Neves, S. D. de Souza, P. Grundy, 2011, Cell Death and Disease.

Decreased E-cadherin expression correlates with higher stage of Wilms' tumors.

R. Bentley, P. Grundy, S. Langdon, 2005, Journal of pediatric surgery.

Characteristics and survival of 750 children diagnosed with a renal tumor in the first seven months of life: A collaborative study by the SIOP/GPOH/SFOP, NWTSG, and UKCCSG Wilms tumor study groups

K. Pritchard-Jones, C. Patte, P. Grundy, 2008, Pediatric blood & cancer.

Hepatic Metastasis at Diagnosis in Patients With Wilms Tumor is not an Independent Adverse Prognostic Factor for Stage IV Wilms Tumor: A Report From the Children's Oncology Group/National Wilms Tumor Study Group

James R. Anderson, D. Green, J. Dome, 2009, Annals of surgery.

16q loss of heterozygosity and microsatellite instability in Wilms' tumor.

P. Goodfellow, P. Grundy, M. Skinner, 2000, Journal of pediatric surgery.

Decrease in LDL receptor‐related protein expression and function correlates with advanced stages of Wilms tumors

B. Annabi, P. Grundy, R. Desrosiers, 2006, Pediatric blood & cancer.

A Coding Variant in RARG Confers Susceptibility to Anthracycline-Induced Cardiotoxicity in Childhood Cancer

Smita H. Karande, C. Portwine, D. Johnston, 2015, Nature Genetics.

Anthropomorphic measurements and event‐free survival in patients with favorable histology Wilms tumor: A report from the Children's Oncology Group

James R. Anderson, D. Green, J. Dome, 2009, Pediatric blood & cancer.

Treatment of recurrent clear cell sarcoma of the kidney with brain metastasis

L. Diller, C. Moertel, J. Dome, 2008, Pediatric blood & cancer.

Outcome of clear cell sarcoma of the kidney (CCSK) treated on the National Wilms Tumor Study-5 (NWTS).

N. Breslow, D. Green, M. Coppes, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comparative genomic hybridization and its application to Wilms’ tumorigenesis

G. Landes, T. Houseal, J. Cowell, 1998, Cytogenetic and Genome Research.

Papillary renal cell carcinoma: report of a rare entity in childhood with review of the clinical management.

P. Metcalfe, P. Grundy, C. Sergi, 2011, Journal of pediatric surgery.

IFI16 is a novel WT1-associated protein identified by expression profiling in syndromic versus sporadic wilms tumors

B. Tycko, J. Licht, D. Choubey, 2006 .

Second malignant neoplasms after childhood non-central nervous system embryonal tumours in North America: A population-based study.

R. Hung, P. Grundy, J. Pole, 2017, European journal of cancer.

A phase 2 study of vincristine and irinotecan in metastatic diffuse anaplastic Wilms tumor: Results from the Children’s Oncology Group AREN0321 study.

James R. Anderson, J. Dome, P. Grundy, 2014 .

Clinical outcome and biological predictors of relapse following nephrectomy only for very low risk Wilms tumor (VLR WT): A report from Children’s Oncology Group AREN0532.

James R. Anderson, J. Dome, P. Grundy, 2015 .

Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumour

A. Feinberg, P. Grundy, M. Steenman, 1994, Nature Genetics.

A genome-wide association study identifies susceptibility loci for Wilms tumor

S. Seal, N. Rahman, A. Naranjo, 2012, Nature Genetics.

Omission of lung radiation in patients with stage IV favorable histology Wilms Tumor (FHWT) showing complete lung nodule response after chemotherapy: A report from Children's Oncology Group study AREN0533.

James R. Anderson, J. Dome, P. Grundy, 2015 .

Treatment of stage IV favorable histology Wilms tumor with incomplete lung metastasis response after chemotherapy: A report from Children's Oncology Group study AREN0533.

James R. Anderson, J. Dome, P. Grundy, 2014 .

Abstract 5413: Terry Fox PRecision Oncology For Young peopLE (PROFYLE): A Canadian precision medicine program for children, adolescents and young adults with hard-to-treat cancer

Steven J. M. Jones, P. Sorensen, D. Eisenstat, 2020 .

Array CGH profiling of favourable histology Wilms tumours reveals novel gains and losses associated with relapse

K Fenwick, A. Ashworth, O. Dovey, 2006, The Journal of pathology.

Evaluating the ability to detect change of health‐related quality of life in children with Hodgkin disease

P. Grundy, M. Krahn, R. Klaassen, 2010, Cancer.

Principles and Practice of Pediatric Oncology (Fifth edition)

J. Dome, P. Grundy, E. Perlman, 2006 .

Gain of 1q is associated with inferior event‐free and overall survival in patients with favorable histology Wilms tumor: A report from the Children's Oncology Group

James R. Anderson, J. Dome, P. Grundy, 2013, Cancer.

Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group Study AREN0532.

James R. Anderson, J. Dome, P. Grundy, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment of children with favorable histology Wilms tumor with extrapulmonary metastases: A report from the COG studies AREN0533 and AREN03B2 and NWTSG study NWTS‐5

J. Dome, P. Grundy, J. Geller, 2023, Cancer.